心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2018 ERC复苏指南：心脏骤停抗心律失常药物的应用（更新版）

2018-11-26 欧洲复苏委员会 Resuscitation. 2018 Nov 26.

心肺复苏心脏骤停抗心律失常药物

2018年11月，欧洲复苏委员会(ERC)更新了复苏指南中关于心脏骤停抗心律失常药物的应用建议，2018欧洲更新版复苏指南主要聚焦心脏骤停高级生命支持期间抗心律失常药物的作用。

中文标题：

2018 ERC复苏指南：心脏骤停抗心律失常药物的应用（更新版）

英文标题：

European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest.

发布机构：

欧洲复苏委员会

发布日期：

2018-11-26

简要介绍：

2018年11月，欧洲复苏委员会(ERC)更新了复苏指南中关于心脏骤停抗心律失常药物的应用建议，2018欧洲更新版复苏指南主要聚焦心脏骤停高级生命支持期间抗心律失常药物的作用。 

拓展指南：与心肺复苏相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ERC复苏指南：心脏骤停抗心律失常药物的应用（更新版）)] GetToolGuiderByIdResponse(projectId=1, id=e24591c0016e1926, title=2018 ERC复苏指南：心脏骤停抗心律失常药物的应用（更新版）, enTitle=European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest., guiderFrom=Resuscitation. 2018 Nov 26., authorId=null, author=, summary=2018年11月，欧洲复苏委员会(ERC)更新了复苏指南中关于心脏骤停抗心律失常药物的应用建议，2018欧洲更新版复苏指南主要聚焦心脏骤停高级生命支持期间抗心律失常药物的作用。 , cover=, journalId=null, articlesId=null, associationId=425, associationName=欧洲复苏委员会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Nov 26 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年11月，欧洲复苏委员会(ERC)更新了复苏指南中关于心脏骤停抗心律失常药物的应用建议，2018欧洲更新版复苏指南主要聚焦心脏骤停高级生命支持期间抗心律失常药物的作用。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>心肺复苏</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=aba3c1c0016e0193" title="2018年美国心脏协会心肺复苏与心血管急救指南更新解读—抗心律失常药物在成人心脏骤停高级生命支持及自主循环恢复后的应用" target=_blank>2018年美国心脏协会心肺复苏与心血管急救指南更新解读—抗心律失常药物在成人心脏骤停高级生命支持及自主循环恢复后的应用</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=69e961c001661580" title="2018 AHA心肺复苏与心血管急救指南：心跳骤停期间和之后应用抗心律失常药物进行高级生命支持（更新）" target=_blank>2018 AHA心肺复苏与心血管急救指南：心跳骤停期间和之后应用抗心律失常药物进行高级生命支持（更新）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d57e01c001661a32" title="2018 AHA心肺复苏与心血管急救指南：儿童高级生命支持（更新）" target=_blank>2018 AHA心肺复苏与心血管急救指南：儿童高级生命支持（更新）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6f7e51c0016a04e5" title="成人院内心肺复苏质量控制临床实践专家共识" target=_blank>成人院内心肺复苏质量控制临床实践专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=95b021c001598a82" title="2018中国心肺复苏培训专家共识" target=_blank>2018中国心肺复苏培训专家共识</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%82%BA%E5%A4%8D%E8%8B%8F" target=_blank>有关心肺复苏更多指南</a></ul>, tagList=[TagDto(tagId=70, tagName=心肺复苏), TagDto(tagId=885, tagName=心脏骤停), TagDto(tagId=20420, tagName=抗心律失常药物)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14509, appHits=844, showAppHits=9, pcHits=7208, showPcHits=7379, likes=269, shares=13, comments=11, approvalStatus=1, publishedTime=Wed Dec 05 22:51:47 CST 2018, publishedTimeString=2018-11-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Dec 05 22:51:47 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:28:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ERC复苏指南：心脏骤停抗心律失常药物的应用（更新版）)])
2018 ERC复苏指南：心脏骤停抗心律失常药物的应用（更新版）
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2170742, encodeId=418b21e07428e, content=需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Fri Nov 24 14:06:38 CST 2023, time=2023-11-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999204, encodeId=33769992041e, content=多么好的软件，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/b89596a08de0490c91d300c31001551c/94c08ce26c314d2a907f495675a14897.jpg, createdBy=18745548271, createdName=ms9000001698161719, createdTime=Tue Jul 13 21:16:38 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997692, encodeId=eac299e6926e, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:19:19 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997690, encodeId=913b99e690b9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>经久不衰, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:18:57 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997689, encodeId=4df899e689f0, content=确实很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:17:13 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2023-11-24 1441fef2m15暂无昵称 来自福建省

    需要学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2170742, encodeId=418b21e07428e, content=需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Fri Nov 24 14:06:38 CST 2023, time=2023-11-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999204, encodeId=33769992041e, content=多么好的软件，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/b89596a08de0490c91d300c31001551c/94c08ce26c314d2a907f495675a14897.jpg, createdBy=18745548271, createdName=ms9000001698161719, createdTime=Tue Jul 13 21:16:38 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997692, encodeId=eac299e6926e, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:19:19 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997690, encodeId=913b99e690b9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>经久不衰, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:18:57 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997689, encodeId=4df899e689f0, content=确实很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:17:13 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-13 ms9000001698161719

    多么好的软件，好好学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2170742, encodeId=418b21e07428e, content=需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Fri Nov 24 14:06:38 CST 2023, time=2023-11-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999204, encodeId=33769992041e, content=多么好的软件，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/b89596a08de0490c91d300c31001551c/94c08ce26c314d2a907f495675a14897.jpg, createdBy=18745548271, createdName=ms9000001698161719, createdTime=Tue Jul 13 21:16:38 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997692, encodeId=eac299e6926e, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:19:19 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997690, encodeId=913b99e690b9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>经久不衰, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:18:57 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997689, encodeId=4df899e689f0, content=确实很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:17:13 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-08 ms7000001887254560

    好好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2170742, encodeId=418b21e07428e, content=需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Fri Nov 24 14:06:38 CST 2023, time=2023-11-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999204, encodeId=33769992041e, content=多么好的软件，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/b89596a08de0490c91d300c31001551c/94c08ce26c314d2a907f495675a14897.jpg, createdBy=18745548271, createdName=ms9000001698161719, createdTime=Tue Jul 13 21:16:38 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997692, encodeId=eac299e6926e, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:19:19 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997690, encodeId=913b99e690b9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>经久不衰, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:18:57 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997689, encodeId=4df899e689f0, content=确实很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:17:13 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-08 ms7000001887254560

    #心血管#经久不衰

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2170742, encodeId=418b21e07428e, content=需要学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Fri Nov 24 14:06:38 CST 2023, time=2023-11-24, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=999204, encodeId=33769992041e, content=多么好的软件，好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/b89596a08de0490c91d300c31001551c/94c08ce26c314d2a907f495675a14897.jpg, createdBy=18745548271, createdName=ms9000001698161719, createdTime=Tue Jul 13 21:16:38 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997692, encodeId=eac299e6926e, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:19:19 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997690, encodeId=913b99e690b9, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>经久不衰, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:18:57 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997689, encodeId=4df899e689f0, content=确实很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd9c5514926, createdName=ms7000001887254560, createdTime=Thu Jul 08 21:17:13 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-08 ms7000001887254560

    确实很好

    0

相关指南

2018年美国心脏协会心肺复苏与心血管急救指南更新解读—抗心律失常药物在成人心脏骤停高级生命支持及自主循环恢复后的应用

暂未更新 · 2018-11-20

2018 AHA心肺复苏与心血管急救指南：心跳骤停期间和之后应用抗心律失常药物进行高级生命支持（更新）

美国心脏协会(AHA,American Heart Association) · 2018-11-05

2018 AHA心肺复苏与心血管急救指南：儿童高级生命支持（更新）

美国心脏协会(AHA,American Heart Association) · 2018-11-05

成人院内心肺复苏质量控制临床实践专家共识

国内急诊/重症相关专家小组（统称） · 2018-08-30

2018 AHA科学声明：婴儿以及儿童心脏病患者心肺复苏

美国心脏协会(AHA,American Heart Association) · 2018-04-23

2017年AAN减轻心肺复苏后脑损伤临床实践指南的解读

暂未更新 · 2018-02-20